A Feasibility Study of a Wearable Arrhythmia Monitoring System (PulseON) in Stroke Patients (Crypto PulseON)
To evaluate the usability of the Pulse ON wearable device in patients with cryptogenic stroke/TIA
研究概览
详细说明
The research project aims to evaluate the usability of a new device for detecting heart rhythm disturbances, especially atrial fibrillation (AF) in people who have had a stroke or mini-stroke (transient ischaemic attack [TIA]) of unknown cause (cryptogenic stroke). AF can be a major cause of disabling strokes and AF-related stroke risk is significantly reduced by starting specific blood thinners called anticoagulants.
Stroke is a major public health concern worldwide, with approximately 100,000 cases annually in the UK alone, making it a leading cause of death and disability. Around 38,000 stroke-related deaths occur each year, and many survivors experience significant long-term impairment. The vast majority (~90%) are ischaemic strokes, yet in 20-40% of cases, no definitive underlying cause is identified, despite extensive evaluation. These cryptogenic stroke cases remain a diagnostic challenge. Cryptogenic strokes are more common in younger stroke patients (<60 years) but can affect all age groups.
AF is the most common arrhythmia and a well-established cause of ischaemic stroke, responsible for 15-30% of cases. However, in cryptogenic stroke, AF often goes undiagnosed because it can come and go (i.e. is paroxysmal) and can be asymptomatic in nature, with episodes that can last for short periods of time but carry high risk of stroke. Early and accurate diagnosis of AF is crucial, as clinical trials have demonstrated the efficacy of oral anticoagulation in significantly reducing stroke risk. Thus, identifying AF in cryptogenic stroke patients can directly impact management by shifting treatment towards anticoagulation.
Background. Detecting AF in cryptogenic stroke is a major challenge and many methods fail to capture episodes of AF that come and go (paroxysmal). Conventional AF detection methods, such as in-hospital cardiac monitoring, serial ECGs, Holter monitors, external event recorders, wearable devices and implantable loop recorders (ILRs), vary in effectiveness. ILRs are small devices (the size of a pen-lid) implanted under the skin of the left chest wall and have a battery life of around three years. They have demonstrated superior diagnostic sensitivity, as highlighted in the CRYSTAL-AF trial, which showed their advantage over standard monitoring in cryptogenic stroke (AF detection rate of 12.4% for ILRs vs 2% for standard monitoring at 12 months). However, ILRs are invasive (which comes with its own procedure-related risks), costly, and may not be suitable for all patients.2 We want to evaluate a different type of AF detection device (the PulseON Arrhythmia Monitor System) that is not currently used in standard care, one that's wrist worn and non-invasive.
Proposed trial We propose a single centre, single arm feasibility pilot study designed to evaluate how practical and user friendly it is for participants to use the PulseON Arrhythmia Monitor System for detecting AF in addition to their normal standard of care. The study will explore whether participants can wear the device as intended, respond to alerts and successfully carry out ECG recordings using the system, whilst capturing their user experience and having their heart tracings closely monitored by health care professionals.
Trial population At UHCW NHS Trust, we manage approximately 1,400 strokes annually (with 350 classified as cryptogenic), many of whom will need to be monitored for AF. While most patients undergo Holter monitoring for AF, a smaller subset receive ILRs but their use is limited due their cost and invasive nature. The introduction of this PulseON device could significantly enhance AF detection, improving patient outcomes, be more cost-effective and optimise resource utilisation within our hospital and the broader NHS. We plan to evaluate whether cardiac monitoring with the PulseON system is feasible in patients with cryptogenic stroke/TIA. This evaluation project may inform wider research into this device and potential NHS implementation.
Treatment / Intervention We aim to recruit twelve patients who have experienced a cryptogenic ischaemic stroke or TIA within the past six months for this project. All patients who participate in the project will receive conventional standard of care investigations (Holter monitoring or ILR) in addition to the PulseON Arrhythmia monitoring system. The data collected will include experience of device usability via an MS forms questionnaire and a follow-up patient interview, baseline demographics, usability data and any newly detected arrhythmia observed from the heart tracing data, in particular AF (defined as an episode of AF lasting >30seconds). Any arrhythmia documented from the PulseON device will be uploaded and stored in an encrypted and secure cloud-based server.
Participants heart tracing data will be collected and reviewed by a suitably qualified healthcare professional within the study team (primarily the Principal Investigator).The reviewer will assess any detected cardiac events to determine their clinical significance and, when appropriate, will escalate relevant findings to the participant's clinical care team. This process ensures that any new or emerging information arising from the study is used to support and inform the provision of standard clinical care for participants.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Andrew White
- 电话号码:02476968582
- 邮箱:andrew.white@uhcw.nhs.uk
学习地点
-
-
-
Coventry、英国、CV2 2DX
- 招聘中
- University Hospital Coventry & Warwickshire NHS Trust
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients diagnosed with cryptogenic stroke/TIA
描述
Inclusion Criteria:
- Adult patients (>18yrs old) diagnosed with cryptogenic stroke / TIA
- Baseline electrocardiogram (ECG), Holter monitor and echocardiogram as part of the standard of care cardiac work-up in the diagnosis of cryptogenic stroke
Exclusion Criteria:
- Patients unwilling or unable to wear the PulseON arrhythmia detection device.
- Known pre-existing AF or atrial arrhythmia diagnosis.
- Participants without capacity will be excluded from this study.
- Participants who are pregnant will be excluded from this study.
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Usability & Feasibility of PulseON wearable device
大体时间:1 month minimum
|
We will collect patient questionnaires and perform patient interviews to gather data on the PulseON device for usability and feasibility data. Formal feedback from health professionals who follow up the trial participants via the PulseON arrhythmia monitoring system online will be obtained. |
1 month minimum
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The prevalence of AF in people who have had cryptogenic ischaemic stroke or TIA.
大体时间:1 month
|
The ability of Pulse ON in detecting AF on ECG and how it differs from the standard of care (ECG, Holter monitoring or ILR) |
1 month
|
|
Baseline characteristics of cohort
大体时间:1 month
|
Baseline demographic and clinical characteristics |
1 month
|
合作者和调查者
调查人员
- 研究主任:Faizel Osman、University Hospital Coventry & Warwickshire
- 首席研究员:Ven G Lim、University Hospital Coventry & Warwickshire
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.